These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21057482)

  • 1. What's fueling the biotech engine-2009-2010.
    Aggarwal S
    Nat Biotechnol; 2010 Nov; 28(11):1165-71. PubMed ID: 21057482
    [No Abstract]   [Full Text] [Related]  

  • 2. What's fueling the biotech engine--2010 to 2011.
    Aggarwal S
    Nat Biotechnol; 2011 Dec; 29(12):1083-9. PubMed ID: 22158359
    [No Abstract]   [Full Text] [Related]  

  • 3. What's fueling the biotech engine-2011 to 2012.
    Aggarwal SR
    Nat Biotechnol; 2012 Dec; 30(12):1191-7. PubMed ID: 23222785
    [No Abstract]   [Full Text] [Related]  

  • 4. What's fueling the biotech engine-2007.
    Aggarwal S
    Nat Biotechnol; 2008 Nov; 26(11):1227-33. PubMed ID: 18997759
    [No Abstract]   [Full Text] [Related]  

  • 5. What's fueling the biotech engine-2012 to 2013.
    Aggarwal RS
    Nat Biotechnol; 2014 Jan; 32(1):32-9. PubMed ID: 24406926
    [No Abstract]   [Full Text] [Related]  

  • 6. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 7. Fresh from the biologic pipeline-2009.
    Sheridan C
    Nat Biotechnol; 2010 Apr; 28(4):307-10. PubMed ID: 20379168
    [No Abstract]   [Full Text] [Related]  

  • 8. What's fueling the biotech engine--2008.
    Aggarwal S
    Nat Biotechnol; 2009 Nov; 27(11):987-93. PubMed ID: 19898448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Biosimilar' drugs poised to penetrate market.
    Ledford H
    Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
    [No Abstract]   [Full Text] [Related]  

  • 10. The next generation?
    Nat Biotechnol; 2006 Nov; 24(11):1300. PubMed ID: 17093454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotech plummets in 3Q11.
    Yang W
    Nat Biotechnol; 2011 Nov; 29(11):962. PubMed ID: 22068525
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 13. The biotech drug market.
    Lawrence S
    Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
    [No Abstract]   [Full Text] [Related]  

  • 14. Weighing the outcomes.
    Russo MJ; Balekdjian D
    Nat Biotechnol; 2008 Feb; 26(2):173-82. PubMed ID: 18259169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brand biologics grab 12 years' exclusivity, for now.
    Osborne R
    Nat Biotechnol; 2009 Aug; 27(8):677-8. PubMed ID: 19668153
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 17. Profit-hungry pharma sees some biotechs as ripe for the picking.
    Willyard C
    Nat Med; 2009 May; 15(5):466. PubMed ID: 19424184
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotech on pace for record year.
    Yang W
    Nat Biotechnol; 2011 Sep; 29(9):780. PubMed ID: 21904312
    [No Abstract]   [Full Text] [Related]  

  • 19. Becoming an American company: a holistic approach to decision making.
    Banerjee PK
    Nat Biotechnol; 2007 Mar; 25(3):277-80. PubMed ID: 17447269
    [No Abstract]   [Full Text] [Related]  

  • 20. Public biotech 2008--the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2009 Aug; 27(8):710-21. PubMed ID: 19668175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.